Serabi Gold plc Notice Of General Meeting
April 28 2021 - 6:30AM
UK Regulatory
TIDMSRB
For immediate release
28 April 2021
Serabi Gold plc
("Serabi" or the "Company")
Notice of General Meeting
The Company announces that a General Meeting will be held on Tuesday 25
May 2021, at The Long Barn, Cobham Park Road, Downside, Surrey KT11 3NE
England at 10.00 am (BST). The Company has published the formal notice
of the meeting (the "Notice") on its website which can be accessed using
the following link
https://www.globenewswire.com/Tracker?data=PN2GN3ugmDjOQDaCqdAt6VB3-cqwR7_3EyVvQCUBmYJ4qy3hlu4_c5Y9g-A18CRE1GM2LBHnLDUG6NrnGGw8jA7RnhEzk64rH-r0wnyaEcE=
https://bit.ly/3dMm7at. Proxy voting forms are being posted to all
shareholders providing details of how to access the Notice and
instructions for voting. A copy of the Notice together with proxy voting
forms is being posted to all shareholders who are required to receive or
have formally requested to receive these documents.
The Notice contains a letter from the Chairman of the Company, Mr
Nicolas Bañados, which is set out below in the Appendix.
Changes to the format of the General Meeting
The Board continues to closely monitor developments in relation to the
Covid-19 pandemic and the health and wellbeing of the Company's
shareholders and employees continue to remain of paramount importance.
As a result of the UK Government's current guidance on social distancing
and the prohibition on public gatherings due to the Covid-19 pandemic,
it is expected that shareholders will not be permitted to attend the
General Meeting.
The General Meeting will be convened in accordance with the Company's
Articles of Association and in line with the UK Government guidance. The
Company will make arrangements such that the legal requirements to hold
the General Meeting can be satisfied through the attendance of a minimum
number of people who are essential for the business of the General
Meeting, and the format of the General Meeting will be purely
functional. Having regard to their own safety and that of others, the
Board respectfully requests that, if these restrictions remain in place
at the time of the General Meeting (as they are expected to),
shareholders comply with the UK Government's current guidance and do not
make plans to attend the General Meeting.
To ensure the safety of the limited number of people whose attendance at
the General Meeting is essential, we will not be able to allow any other
Shareholders to gain access to the General Meeting on the day. If it
becomes possible to admit Shareholders to the General Meeting, we will
make an announcement on our website (www.serabigold.com) and via a
Regulatory Information Service. To ensure that Shareholders' votes are
counted, the Board strongly encourages all Shareholders to exercise
their right to vote by appointing the Chairman of the General Meeting as
their proxy to vote at the General Meeting on their behalf, in
accordance with their instructions. Shareholders should not appoint any
person other than the Chairman of the General Meeting to act as their
proxy, as that person will likely not be granted access to the General
Meeting on the day and their appointing shareholder's votes will not be
able to be counted.
(1) Certain resolutions to be proposed at the meeting will be
special resolutions requiring approval of more than 75% of the votes
cast. Under Canadian National Instrument 54-101, the meeting therefore
also constitutes a Special Meeting.
Enquiries:
Serabi Gold plc
Michael Hodgson Tel: +44 (0)20 7246 6830
Chief Executive Mobile: +44 (0)7799 473621
Clive Line Tel: +44 (0)20 7246 6830
Finance Director Mobile: +44 (0)7710 151692
Email: contact@serabigold.com
------------------------------
Website: www.serabigold.com
------------------------------
Beaumont Cornish Limited
Nominated Adviser
Roland Cornish Tel: +44 (0)20 7628 3396
Michael Cornish Tel: +44 (0)20 7628 3396
Peel Hunt LLP
UK Broker
Ross Allister Tel: +44 (0)20 7418 9000
CAMARCO
Investor and Public Relations
Gordon Poole Tel:+ 44 (0)20 3757 4997
Nick Hennis
Emily Hall
Copies of this announcement are available from the Company's website at
https://www.globenewswire.com/Tracker?data=bHkFewH0uu_zofouY3Y14NiiQUtWm40--_AwZDanJRWsFBg_4DYtfLAuIqg7_O9BlOETfUBld4GF2Z0XRP9dWX-c61d_DiGuv6dsBg1B-dY=
www.serabigold.com.
Neither the Toronto Stock Exchange, nor any other securities regulatory
authority, has approved or disapproved of the contents of this
announcement.
Appendix 1
The letter from the Chairman of the Company included in the Notice is
reproduced below (without material adjustment):
Dear Shareholder
Introduction
On 2 March 2021, the Company announced it had raised GBP12.5 million
(approximately US$17.5 million) (before expenses) by way of the Share
Placing and PrimaryBid Offer to institutional and other investors at a
price of 75 pence per Ordinary Share. The Company also announced that it
had secured conditional subscriptions for 4,003,527 Warrants at an issue
price of GBP0.06 (C$0.11) per Warrant to raise gross proceeds of
approximately US$0.3 million (GBP0.2 million / C$0.4 million), subject
amongst other things to shareholder approval at the General Meeting. The
Warrants will have an Exercise Price of GBP0.9375 (C$1.65) per new
Ordinary Share and will be exercisable for two years from their date of
issue.
The purpose of this document is to provide the formal notice (the
"Notice") of the General Meeting to be held at The Long Barn, Cobham
Park Road, Downside, Cobham, Surrey, KT11 3NE, England on 25 May 2021 at
10 a.m. (London time) at which the Resolutions to approve the issue of
the Warrants will be proposed. .
Canadian Designated Foreign Issuer Status
The Company is a "designated foreign issuer" for the purposes of
Canadian Securities Administrators' National Instrument 71-102 --
Continuous Disclosure and Other Exemptions Relating to Foreign Issuer
("NI 71-102"), and, as such, the Company is not subject to the same
ongoing reporting requirements as most other reporting issuers in
Canada. Generally, the Company complies with Canadian ongoing reporting
requirements by complying with the regulatory requirements of AIM, which
is a "foreign regulatory authority" (as defined in NI 71-102), and
filing any documents required to be filed with or furnished to AIM with
the securities regulatory authorities in Canada.
Background to and reasons for the issue of the Warrants
On 2 March 2021, the Company announced that it had placed with new and
existing investors a total of 16,650,000 new Ordinary Shares in the
capital of the Company at a Placing Price of GBP0.75 (C$1.32) per new
Ordinary Share. At the same time and pursuant to the Warrant Placing,
the Company also secured commitments from investors to subscribe for
4,003,527 Warrants at an issue price of GBP0.06 (C$0.11) per Warrant
raising gross proceeds of US$0.3 million (GBP0.2 million / C$0.4
million), subject amongst other things to shareholder approval at the
General Meeting.
The Warrants will have an Exercise Price of GBP0.9375 (C$1.65) per new
Ordinary Share and will be exercisable for two years from their date of
issue. Accordingly, if all the Warrants are exercised, the aggregate
exercise price receivable by the Company in respect of the 4,003,527 new
Ordinary Shares would be an additional amount of approximately GBP3.75
million.
During the course of planning for the Share Placing, the Company, after
consultation with the Joint Bookrunners and the Manager, had decided
that in order to secure the best terms for the Share Placing and to
widen the appeal of the Share Placing for investors, it was appropriate
that investors should be given the opportunity to subscribe for
Warrants. Recognising that some investors may have restrictions on their
ability to hold securities which provide future rights to subscribe for
Ordinary Shares, such as the Warrants, it was decided that the Warrants
would be offered by way of a separate subscription.
The Directors believe that the amount that would be paid to the Company
in respect of the Warrants is justified on the basis that: (i) the
Warrant Placing assisted in obtaining the best terms for the Share
Placing, and (ii) the Exercise Price in respect of the Warrants
represented a 25% premium to the Placing Price.
The Warrant Placing
The Warrant Placing is conditional upon, among other things, the
approval of the Resolutions at the General Meeting, and such aspects of
the Placing Agreement as relate specifically to the Warrants becoming
unconditional and the Placing Agreement not being terminated in
accordance with its terms prior to the date of issue of the Warrants.
The Ordinary Shares to be issued pursuant to the exercise of the
Warrants will rank pari passu with the Existing Ordinary Shares.
At the General Meeting, the Company will be seeking to pass both an
ordinary and special resolution (which will require votes in favour from
at least 75% of the Ordinary Shares present and voting at the General
Meeting) in order to give the Directors authority to allot the Warrants
to the Warrant Placees on a non-pre-emptive basis.
Use of proceeds
The Directors intend to use the proceeds from the Warrant Placing which
in total will be GBP0.24 million (before expenses) for the Company's
working capital purposes.
The General Meeting
The Warrant Placing is conditional upon the approval of the Resolutions
by Shareholders at the General Meeting to be held at The Long Barn,
Cobham Park Road, Downside, Cobham, Surrey, KT11 3NE, England on 25 May
2021 at 10 a.m. The notice convening the General Meeting is incorporated
in this document.
At the 2020 Annual General Meeting, the Directors were authorised to
allot 20 million Ordinary Shares on a non-pre-emptive basis. Since the
2020 Annual General Meeting, the Company has allotted 16,650,000
Ordinary Shares and, as a consequence, the Directors do not have
sufficient authority to grant the Warrants. The Company is therefore
proposing to seek specific authorities to grant the Warrants at the
General Meeting. The Directors intend to propose resolutions to renew
the general authorities at the 2021 Annual General Meeting.
Resolution 1 provides the Company with authority to grant the Warrants
and Resolution 2 disapplies the statutory pre-emption rights applicable
to those Warrants.
Resolution 1 will be proposed as an ordinary resolution requiring a
majority of votes cast at the General Meeting to be in favour of it in
order for it to be passed. Resolution 2 will be proposed as a special
resolution requiring 75% of the votes cast at the General Meeting to be
in favour of it for it to be passed.
Shareholders should note that the Resolutions in relation to the
Warrants to be proposed at the General Meeting are inter-conditional and
if any one of them is not passed the Warrant Placing will not be
completed.
Fratelli Investments Limited, which holds shares representing
approximately 25.5% of the Existing Ordinary Shares has irrevocably
undertaken to vote in favour of the Resolutions.
Greenstone Resources II LP, which holds shares representing
approximately 25.2% of the Existing Ordinary Shares has irrevocably
undertaken to vote in favour of the Resolutions.
Coronavirus (Covid-19)
The Board continues to closely monitor developments in relation to the
Covid-19 pandemic and the health and wellbeing of the Company's
shareholders and employees continue to remain of paramount importance.
As a result of the UK Government's current guidance on social distancing
and the prohibition on public gatherings due to the Covid-19 pandemic,
it is expected that shareholders will not be permitted to attend the
General Meeting.
The General Meeting will be convened in accordance with the Company's
Articles of Association and in line with the UK Government guidance. The
Company will make arrangements such that the legal requirements to hold
the General Meeting can be satisfied through the attendance of a minimum
number of people who are essential for the business of the General
Meeting, and the format of the General Meeting will be purely
functional. Having regard to their own safety and that of others, the
Board respectfully requests that, if these restrictions remain in place
at the time of the General Meeting (as they are expected to),
shareholders comply with the UK Government's current guidance and do not
make plans to attend the General Meeting.
To ensure the safety of the limited number of people whose attendance at
the General Meeting is essential, we will not be able to allow any other
Shareholders to gain access to the General Meeting on the day. If it
becomes possible to admit Shareholders to the General Meeting, we will
make an announcement on our website (www.serabigold.com) and via a
Regulatory Information Service. To ensure that Shareholders' votes are
counted, the Board strongly encourages all Shareholders to exercise
their right to vote by appointing the Chairman of the General Meeting as
their proxy to vote at the General Meeting on their behalf, in
accordance with their instructions. Shareholders should not appoint any
person other than the Chairman of the General Meeting to act as their
proxy, as that person will likely not be granted access to the General
Meeting on the day and their appointing shareholder's votes will not be
able to be counted.
Shareholders are encouraged to submit their proxy forms or voting
instructions online following the details set out in the Proxy
Instructions that accompanies this Circular. Alternatively, Shareholders
can return their proxy forms or voting instructions by post following
the instructions provided in this Circular. Proxy appointments or voting
instructions should be received as soon as possible and must be received
by no later than 10:00 am (London time) on 20 May 2021 in order to be
valid.
Despite these necessary changes to the format of the General Meeting,
the Board wants to ensure that shareholders have an opportunity to
engage with the Company and the Board. Shareholders are encouraged to
submit questions in advance of the General Meeting, by emailing
EGM2021@serabigold.com and including "EGM 2021" in the subject line. We
will endeavour to answer these questions on the Company's website prior
to the General Meeting. It is not the intention at this time to arrange
a formal Q&A webinar to coincide with the General Meeting.
The health of our shareholders and colleagues remains our priority and
the steps set out above are necessary to ensure their well-being during
the Covid-19 pandemic.
Action to be taken by Shareholders
A Form of Proxy for use by Shareholders at the General Meeting
accompanies this document. To be valid, Forms of Proxy must be completed
and returned so as to be received at either the offices of the Company's
UK Registrar, Computershare Investor Services Plc, The Pavilions,
Bridgwater Road, Bristol, BS99 6ZZ or the offices of the Company's
Canadian Registrar, Computershare Investor Services Inc., 100 University
Avenue, 8th Floor, Toronto, Ontario M5J 2Y1 by not later than 10 a.m.
(London time) (5 am Eastern time) on 20 May 2021. Alternatively,
Shareholders can submit their Proxy to Computershare UK through CREST by
not later than not later than 10 a.m. (London time) on 20 May 2021 in
accordance with the procedures set out in the Form of Proxy. The Board
strongly encourages all Shareholders to exercise their right to vote by
appointing the Chairman of the General Meeting as their proxy to vote at
the General Meeting on their behalf, in accordance with their
instructions. Shareholders should not appoint any person other than the
Chairman of the General Meeting to act as their proxy, as that person
will likely not be granted access to the General Meeting on the day and
their appointing Shareholder's votes will not be able to be counted.
Completion and return of a Form of Proxy will not ordinarily prevent
Shareholders from attending and voting in person at the General Meeting
should they so wish. However, as set out above, the General Meeting will
likely be held as a closed meeting and Shareholders will not be
permitted to attend due to the Covid-19 restrictions.
Beneficial Shareholders should note that only registered Shareholders or
their duly authorised proxy holders are entitled to vote at the General
Meeting. Each Beneficial Shareholder should ensure that their voting
instructions are communicated to the appropriate person well in advance
of the General Meeting.
Further details of the restrictions and steps to be taken with respect
to voting are set out in the Notice and Management Information Circular
contained in this document.
Recommendation and importance of vote
Shareholders should be aware that, if the Resolutions are not approved
at the General Meeting, the net proceeds of the Warrant Placing will not
be received by the Company.
The Directors consider that the Resolutions set out in the Notice and
being put to the General Meeting are in the best interests of the
Company and its Shareholders and are most likely to promote the success
of the Company for the benefit of the Shareholders as a whole.
Accordingly, the Directors unanimously recommend that Shareholders vote
in favour of the proposed Resolutions as they intend to do in respect of
their own holdings, where relevant, amounting to an aggregate of
1,262,345 Ordinary Shares, representing approximately 1.67% of the
Company's Existing Ordinary Shares.
Yours faithfully
(Signed) "Nicolas Bañados"
Nicolas Bañados
Non-executive Chairman
ENDS
(END) Dow Jones Newswires
April 28, 2021 07:30 ET (11:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Serabi Gold (LSE:SRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Serabi Gold (LSE:SRB)
Historical Stock Chart
From Apr 2023 to Apr 2024